Archives

by in
Entry Author Date Location
West Coast Biotech Roundup: Affymax, K2, Roche/Stratos, & More 06/26/14 San Francisco
BIO 2014: Antisense and Disruptive Technologies for Drug Discovery 06/23/14 San Diego
Cubist Wins FDA Approval for New Antibiotic Aimed at Skin Infections 06/21/14 Boston
West Coast Biotech Roundup: Burrill, Topol, Aduro, Receptos, & More 06/19/14 San Francisco
Texas Biotech ZS Pharma Makes Wall Street Debut, Raises $107M 06/18/14 Texas
FDA Delays Action on Orexigen’s Anti-Obesity Drug by 3 Months 06/11/14 San Diego
Merck Scoops Up Idenix in $3.85B Buyout 06/09/14 Boston
Prostate Cancer Screening: Seduction Of The Innocent 05/28/14 Seattle
Radius Health Recharges IPO After Two Week Hiatus 05/21/14 Boston
ZS Pharma Ends Texas Biotech IPO Dry Spell With $86M Pitch 05/20/14 Texas
Ophthotech, Novartis Team up on $1B Deal for Eye Drug 05/19/14 New York
East Coast Biotech Roundup: LTI, SolveBio, Proteon, & More 05/16/14 Boston
Gelesis Resurfaces With $12M, Preps First Weight Loss Data 05/16/14 Boston
Tesaro Climbs on Phase 3 Data for Nausea Drug 05/12/14 Boston
Wisconsin Roundup: BrightStar, Propeller Health, JCI R&D lab, & More 05/09/14 Wisconsin
MCW’s Clarke Wants to Build Critical Mass of Medical Entrepreneurs 05/06/14 Wisconsin
Merrimack Heads to FDA as Pancreatic Cancer Drug Succeeds in Phase 3 05/01/14 Boston
East Coast Biotech Roundup: Sarepta, Alkermes, Boston Biotech, & More 04/25/14 Boston
Sarepta to Submit Application for Duchenne Drug, Shares Boom 04/21/14 Boston
Overstreet, Winner in Startup Tax Battle, Gets $2M for AdverseEvents 04/16/14 San Francisco
San Diego Life Sciences Roundup: Celladon, Halozyme, Zogenix, & More 04/11/14 San Diego
They Still Call it Telemedicine? Tracking the Evolution of HealthIT. 04/11/14 Texas
Celladon Gets FDA’s “Breakthrough Therapy” Status for Gene Therapy 04/10/14 San Diego
Spero Emerges With $3M, Backing From Roche, & Plans to Disarm Bugs 04/09/14 Boston
Alkermes Scores Phase 3 Win for Long-Lasting Schizophrenia Drug 04/08/14 Boston
San Diego Life Sciences Roundup: Halozyme, NuVasive, Lumena, and More 04/07/14 San Diego
San Diego’s Lumena Files for IPO to Fund Liver Drug Trials 04/04/14 San Diego
FDA Lifts Clinical Hold on Curis Cancer Drug, Shares Surge 03/31/14 Boston
Appearing Briefly at Your Next Conference: “Whac-A-Mole” Speakers 03/31/14 Seattle
FDA Panel Gives Exact’s Colon Cancer Test Ringing Endorsement 03/27/14 Wisconsin
Page 3 of 41 « previous page · next page »